Patents by Inventor Ho Sun Jung

Ho Sun Jung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE
    Publication number: 20240172561
    Abstract: Disclosed are a composition for an organic optoelectronic device, an organic optoelectronic device including the same, and a display device. The composition includes a first compound represented by a combination of Chemical Formula 1 and Chemical Formula 2 and a second compound represented by Chemical Formula 3. Details of Chemical Formula 1 to Chemical Formula 3 are as defined in the specification.
    Type: Application
    Filed: March 21, 2022
    Publication date: May 23, 2024
    Inventors: Jonghoon KIM, Youngmook LIM, Hyung Sun KIM, Sung-Hyun JUNG, Ho Kuk JUNG, Dalho HUH
  • COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE
    Publication number: 20240164205
    Abstract: Provided are a composition for an organic optoelectronic device, and an organic optoelectronic device including the same, and a display device, the composition for an organic optoelectronic device including a first compound, a second compound, and a third compound, wherein the first compound is represented by Chemical Formula I or Chemical Formula II, the second compound is represented by Chemical Formula III, and the third compound is represented by Chemical Formula IV. Details of Chemical Formula I, Chemical Formula II, Chemical Formula III and Chemical Formula IV are as described in the specification.
    Type: Application
    Filed: September 2, 2022
    Publication date: May 16, 2024
    Inventors: Hanill LEE, Hyung Sun KIM, Mijin LEE, Sung-Hyun JUNG, Ho Kuk JUNG, Seonyeong GWAK, Wook KIM, Jaehoon KIM, Seungjae LEE, Yoonman LEE, Suheon IM
  • COMBINATIONAL IMMUNOTHERAPIES USING CAR-M, CAR-NK, CAR-EOS, AND CAR-N CELLS
    Publication number: 20240156963
    Abstract: This disclosure provides genetically engineered immune cells that express an anti-GD2 chimeric antigen receptor, methods of generating these cells, and methods of treating tumors using the genetically engineered cells.
    Type: Application
    Filed: April 18, 2023
    Publication date: May 16, 2024
    Inventors: James Thomson, Jue Zhang, Igor Slukvin, Aditi Majumder, Ho Sun Jung
  • COMPOSITION FOR OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE
    Publication number: 20240147849
    Abstract: A composition for an organic optoelectronic device an organic optoelectronic device, and a display device, the composition including a first compound; a second compound; and a third compound, wherein the first compound, the second compound, and the third compound are different from each other, the first compound is represented by Chemical Formula I, the second compound is represented by Chemical Formula I, and the third compound is represented by Chemical Formula II or Chemical Formula III:
    Type: Application
    Filed: December 4, 2023
    Publication date: May 2, 2024
    Inventors: Jinhyun LUI, Dong Min KANG, Hyung Sun KIM, Yongtak YANG, Sung-Hyun JUNG, Ho Kuk JUNG, Youngkyoung JO, Pyeongseok CHO, Dalho HUH, Hyungyu LEE
  • COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE
    Publication number: 20240122066
    Abstract: A compound for an organic optoelectronic device, a composition for an organic optoelectronic device including the same, an organic optoelectronic device, and a display device, the compound is represented by Chemical Formula 1:
    Type: Application
    Filed: September 5, 2023
    Publication date: April 11, 2024
    Inventors: Youngkyoung JO, Mijin LEE, Kipo JANG, Jonghoon KIM, Hyung Sun KIM, Jinhyun LUI, Dong Min KANG, Ho Kuk JUNG, Sunghyun JUNG
  • REAGENTS AND METHODS FOR PRODUCING ERYTHROMYELOID PROGENITOR CELLS, NK CELLS, AND MEGAKARYOCYTES
    Publication number: 20240084257
    Abstract: This disclosure provides reagents and methods for producing NK progenitor cells, NK cells, megakaryocytes and CAR derivatives thereof from hematopoietic stem cells. Pharmaceutical compositions comprising NK progenitor cells produced by the reagents and methods of the invention and immunotherapeutic methods using these pharmaceutical compositions are also provided.
    Type: Application
    Filed: September 7, 2023
    Publication date: March 14, 2024
    Inventors: Igor Slukvin, Ho Sun Jung
  • Protein Tyrosine Phosphatase 1B Inhibited Neutrophils, Neutrophil-Dendritic Cell Hybrids and Uses Thereof
    Publication number: 20230323301
    Abstract: This disclosure provides methods for producing neutrophils under serum-free and feeder-free conditions from protein tyrosine phosphatase 1B (PTP1b)-inhibited pluripotent stem cells. The disclosure further provides PTP1b inhibited neutrophils and uses thereof. Also disclosed are methods for producing human neutrophil-DC hybrid cells and human neutrophil-DC hybrid cells produced thereby.
    Type: Application
    Filed: April 6, 2023
    Publication date: October 12, 2023
    Inventors: Anna Huttenlocher, Igor Slukvin, Morgan Giese, Ho Sun Jung, David Bennin
  • GENERATION OF HOXA-EXPRESSING HEMOGENIC ENDOTHELIUM WITH ENHANCED T CELL POTENTIAL FROM HPSCS
    Publication number: 20210355441
    Abstract: The present invention provides methods of creating a population of hemogenic endothelial cells with arterial specification and enhanced T cell potential. The methods involve inducing the expression of a SOX17 transgene in human pluripotent stem cells starting at day 2 of differentiation. Stem cells that express the SOX17 transgene are also provided.
    Type: Application
    Filed: May 18, 2021
    Publication date: November 18, 2021
    Inventors: Igor Slukvin, Ho Sun Jung